These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 10170623)

  • 1. A skeptical approach to new technology--a cost control strategy.
    Schneider D
    Can J Med Technol; 1990 Aug; 52(3):180-1. PubMed ID: 10170623
    [No Abstract]   [Full Text] [Related]  

  • 2. Technology, the biggest health-care cost-driver of all. Can we curb its rise?
    Terry K
    Med Econ; 1994 Mar; 71(6):124-37. PubMed ID: 10132718
    [No Abstract]   [Full Text] [Related]  

  • 3. Technology assessment and the doctor-patient relationship.
    Wax AL
    Va Law Rev; 1996 Nov; 82(8):1641-62. PubMed ID: 16715567
    [No Abstract]   [Full Text] [Related]  

  • 4. Growing leaner: a cost-cutting strategy.
    Johnson JL
    MLO Med Lab Obs; 1983 May; 15(5):89-90, 93-4, 99. PubMed ID: 10317343
    [No Abstract]   [Full Text] [Related]  

  • 5. The limited regulatory potential of medical technology assessment.
    Elhauge E
    Va Law Rev; 1996 Nov; 82(8):1525-1622. PubMed ID: 16715565
    [No Abstract]   [Full Text] [Related]  

  • 6. Commentary--medical technologies: a perspective of the Carter administration.
    Omenn GS; Ball JR
    Forum Med; 1980 Jun; 3(6):374-5. PubMed ID: 10247163
    [No Abstract]   [Full Text] [Related]  

  • 7. Can technology truly reduce healthcare costs?
    Wells PN
    IEEE Eng Med Biol Mag; 2003; 22(1):20-5. PubMed ID: 12683058
    [No Abstract]   [Full Text] [Related]  

  • 8. Total cost reduction in the laboratory: a team effort.
    Forsman RW
    J Healthc Mater Manage; 1994 Mar; 12(3):14-5, 20, 22. PubMed ID: 10171866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health technology assessment: implications for policymakers.
    Feeny D; Stoddart G
    Dimens Health Serv; 1987 Sep; 64(6):30. PubMed ID: 3653554
    [No Abstract]   [Full Text] [Related]  

  • 10. "Gatekeeper technology." Recasting a primary care role.
    Powe NR
    Consultant; 1987 Jun; 27(6):86-7, 90-1. PubMed ID: 10302835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Life-cycle management: a long-term challenge.
    Newman C
    Med Device Technol; 2003 Apr; 14(3):32-3. PubMed ID: 12789698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. For cost-reducing technologies, knowing markets is to change them.
    Huefner RP; Waitzman N; Andrade JD; Kern SE
    IEEE Eng Med Biol Mag; 2003; 22(1):26-31. PubMed ID: 12683059
    [No Abstract]   [Full Text] [Related]  

  • 13. [Health-care costs and health technology assessment].
    Lettieri E; Masella C
    G Ital Nefrol; 2007; 24 Suppl 40():s22-36. PubMed ID: 18034409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Curbing the high costs of medical advances.
    Schroeder SA
    Bus Health; 1984; 1(8):7-11. PubMed ID: 10317473
    [No Abstract]   [Full Text] [Related]  

  • 15. Illustrating economic evaluation of diagnostic technologies: comparing Helicobacter pylori screening strategies in prevention of gastric cancer in Canada.
    Xie F; O'Reilly D; Ferrusi IL; Blackhouse G; Bowen JM; Tarride JE; Goeree R
    J Am Coll Radiol; 2009 May; 6(5):317-23. PubMed ID: 19394572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beware of technological imperatives and commercial interests that prevent best practices!
    Benner P
    Am J Crit Care; 2003 Sep; 12(5):469-71. PubMed ID: 14503431
    [No Abstract]   [Full Text] [Related]  

  • 17. Saving money in hospitals through a focus on capital expenditure strategy and management.
    Street T
    N Z Health Hospital; 1997; 49(4):8-9. PubMed ID: 10173158
    [No Abstract]   [Full Text] [Related]  

  • 18. Guidelines for evaluating and introducing new tests.
    Peter JB; Berry AJ
    MLO Med Lab Obs; 1983 Jul; 15(7):75-6, 80-4. PubMed ID: 10317372
    [No Abstract]   [Full Text] [Related]  

  • 19. The appropriateness of medical services.
    Kosecoff J; Fink A; Chassin MR; Brook RH
    Healthspan; 1987 Jun; 4(6):18-21. PubMed ID: 10283095
    [No Abstract]   [Full Text] [Related]  

  • 20. HFMA roundtable. Capital planning: how strategic is your organization?
    Frederick C; Lux RH; Morris J; O'Connell B; Wiest J; Fincher N
    Healthc Financ Manage; 2006 Jul; 60(7):suppl 1-4 following 32. PubMed ID: 16869319
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.